Drugs

Indian Medicines Pharmaceutical Corporation Limited (IMPCL), a Central Public Sector Enterprise (CPSE) earmarked for divestment by the government, has seen its asset valuation expand by 80% over the past five years, reaching the fiscal year 2023-24. IMPCL’s net worth climbed […]

Dr. Uday Saxena emphasized that the framework for conducting oncology clinical trials is maturing, thereby hastening the delivery of superior drugs to Indian patients over the coming decade. India is experiencing significant progress in cancer medication and treatment innovation, remarked

A growing interest in cost-effective respiratory solutions is being observed in both urban and rural sectors nationwide, spurred by an enhanced understanding of respiratory health post-Covid-19, according to a sector specialist. Suhas Shubhakaran, the co-founder of Oxymed under Karnataka-based Medequip

Mesoblast Limited, a leader in cellular medicine for inflammatory conditions, has revealed that the US FDA has awarded their allogeneic stromal cell therapy, Revascor (rexlemestrocel-L), the Regenerative Medicine Advanced Therapy (RMAT) designation. This follows promising outcomes from a trial centered

The Ministry of Chemicals and Fertilisers highlights the significance of nafithromycin, India’s inaugural native macrolide antibiotic, which is currently pending final authorization from the Central Drugs Standard Control Organization (CDSCO). This breakthrough represents a monumental moment in tackling antimicrobial resistance,

Traya, India’s pioneering health-tech company focusing on internal solutions for hair loss, released groundbreaking findings from an unprecedented clinical study comparing the effectiveness of Traya’s hair loss regimen to minoxidil, a widely used treatment, in addressing hair loss issues. This

The Ministry of Health and Family Welfare has challenged recent reports claiming an alleged scarcity of tuberculosis medications in India, describing such assertions as false and misleading. As of December 6, 2024, the National Tuberculosis Elimination Programme (NTEP) boasts over

Centerline Biomedical Inc, a pioneering force in cardiovascular navigation and visualization technology, has achieved the U.S. Food and Drug Administration’s (FDA) 510(k) clearance for their newly developed IOPS Guidewire Handle. This represents the latest addition to their unique and patented

A study by the National Institutes of Health (NIH) has unveiled that nearly half of the expectant mothers exhibiting unusual prenatal cell-free DNA (cfDNA) test outcomes were found to harbor hidden cancers. These cancers, which include colorectal, breast, lung, and

Lupin Limited, a global leader in the pharmaceutical industry, has announced it has secured tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application. This approval pertains to abacavir, dolutegravir, and lamivudine tablets